Malaria Vaccine Development Program
In 2004 Initiatives was awarded a task order under the TASC2 Global Health indefinite quantity contract to support USAID’s Malaria Vaccine Development Program (MVDP). In 2010 the task order was extended via the TASC3 IQC mechanism. The program is devoted to developing vaccines to decrease illness and death due to malaria in endemic areas. The program works closely with academia, the commercial sector, other government agencies, and international organizations to fill gaps in the global malaria vaccine development effort by focusing on promising new technologies and developing vaccines that will protect residents in malaria-endemic areas. USAID’s website provides more detail on the program’s approaches and overall achievements.
Initiatives’ role under the MVDP includes management support, including coordination of the annual meetings of the USAID MVDP Scientific Consultant Group, a committee that provides strategic advice to the program. Our Senior Technical Advisor provides management support to program activities, advises on the application of biotechnology to parasitic vaccine development, develops regulatory affairs plans and documents, and coordinates program activities with MVDP partners such as the Malaria Vaccine Initiative at PATH and the National Institute for Allergy and Infectious Diseases. Initiatives also provides a Legal Advisor, who assists USAID in dealing with MVDP partners on issues involving intellectual property.
Initiatives’ other services to the MVDP include coordination of a redesign and re-launch of the Federal Malaria Vaccine Coordinating Committee website. The site went live in April 2010.
Project: Malaria Vaccine Development Program (MVDP)
Prime: Initiatives Inc.